References
- Bonvicini, C., Faraone, S. V., & Scassellati, C. (2018). Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder. The World Journal of Biological Psychiatry, 19(2), 80–100. https://doi.org/10.1080/15622975.2017.1282175
- Budini, M., Buratti, E., Morselli, E., & Criollo, A. (2017). Autophagy and its impact on neurodegenerative diseases: new roles for TDP-43 and C9orf72. Frontiers in Molecular Neuroscience, 10, 170. https://doi.org/10.3389/fnmol.2017.00170
- Byrne, S., Heverin, M., Elamin, M., Walsh, C., & Hardiman, O. (2014). Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(1-2), 148–150. https://doi.org/10.3109/21678421.2013.838586
- Chen, Y., Lin, Z., Chen, X., Cao, B., Wei, Q., Ou, R., & Shang, H. F. (2016). Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiology of Aging, 38, 217.e15-217.e22. [pii]. https://doi.org/10.1016/j.neurobiolaging.2015.11.016
- Conners, J. J., & Obi, L. J. (1968). Conservative treatment of trigger thumb in infants and children. Journal of the Florida Medical Association, 55(9), 819.
- DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., & Rademakers, R. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72(2), 245–256. https://doi.org/10.1016/j.neuron.2011.09.011
- Devenney, E. M., Ahmed, R. M., Halliday, G., Piguet, O., Kiernan, M. C., & Hodges, J. R. (2018). Psychiatric disorders in C9orf72 kindreds: study of 1,414 family members. Neurology, 91(16), e1498–e1507. https://doi.org/10.1212/WNL.0000000000006344
- Ducharme, S., Bajestan, S., Dickerson, B. C., & Voon, V. (2017). Psychiatric presentations of C9orf72 mutation: what are the diagnostic implications for clinicians? The Journal of Neuropsychiatry and Clinical Neurosciences, 29(3), 195–205. https://doi.org/10.1176/appi.neuropsych.16090168
- Fahey, C., Byrne, S., McLaughlin, R., Kenna, K., Shatunov, A., Donohoe, G., & Morris, D. W. (2014). Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample. Neurobiology of Aging, 35(6), 1510.e1-1510.e5. https://doi.org/10.1016/j.neurobiolaging.2013.12.003
- Faraone, S. V., & Larsson, H. (2018). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 24(4), 562-575. https://doi.org/10.1038/s41380-018-0070-0
- Galimberti, D., Reif, A., Dell’osso, B., Kittel-Schneider, S., Leonhard, C., Herr, A., & Scarpini, E. (2014). C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiology of Aging, 35(5), 1214.e7-1214.e10. https://doi.org/10.1016/j.neurobiolaging.2013.12.004
- Galimberti, D., Reif, A., Dell’Osso, B., Palazzo, C., Villa, C., Fenoglio, C., & Scarpini, E. (2014). C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disorders, 16(4), 448–449. https://doi.org/10.1111/bdi.12169
- Gallolu Kankanamalage, S., Lee, A. Y., Wichaidit, C., Lorente-Rodriguez, A., Shah, A. M., Stippec, S., & Cobb, M. H. (2017). WNK1 is an unexpected autophagy inhibitor. Autophagy, 13(5), 969–970. https://doi.org/10.1080/15548627.2017.1286431
- Garcia-Redondo, A., Dols-Icardo, O., Rojas-Garcia, R., Esteban-Perez, J., Cordero-Vazquez, P., Munoz-Blanco, J. L., & Lleo, A. (2013). Analysis of the C 9orf72 gene in patients with amyotrophic lateral sclerosis in spain and different populations worldwide. Human Mutation, 34(1), 79–82. https://doi.org/10.1002/humu.22211
- Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., & Van Broeckhoven, C. (2012). A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. The Lancet Neurology, 11(1), 54–65. https://doi.org/10.1016/S1474-4422(11)70261-7
- Gokcen, C., Kocak, N., & Pekgor, A. (2011). Methylenetetrahydrofolate reductase gene polymorphisms in children with attention deficit hyperactivity disorder. International Journal of Medical Sciences, 8(7), 523–528. https://doi.org/10.7150/ijms.8.523
- Gomez-Tortosa, E., Gallego, J., Guerrero-Lopez, R., Marcos, A., Gil-Neciga, E., Sainz, M. J., & Perez-Perez, J. (2013). C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration. Neurology, 80(4), 366–370. https://doi.org/10.1212/WNL.0b013e31827f08ea
- Lesch, K. P., Timmesfeld, N., Renner, T. J., Halperin, R., RÃ Ser, C., Nguyen, T. T., & Jacob, C. (2008). Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. Journal of Neural Transmission, 115(11), 1573–1585. https://doi.org/10.1007/s00702-008-0119-3
- Meisler, M. H., Grant, A. E., Jones, J. M., Lenk, G. M., He, F., Todd, P. K., & McInnis, M. G. (2013). C9ORF 72 expansion in a family with bipolar disorder. Bipolar Disorders, 15(3), 326–332. https://doi.org/10.1111/bdi.12063
- Millecamps, S., Boillee, S., Le Ber, I., Seilhean, D., Teyssou, E., Giraudeau, M., & Salachas, F. (2012). Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. Journal of Medical Genetics, 49(4), 258–263. https://doi.org/10.1136/jmedgenet-2011-100699
- Ng, A. S. L., & Tan, E. K. (2017). Intermediate C9orf72 alleles in neurological disorders: Does size really matter? Journal of Medical Genetics, 54(9), 591–597. https://doi.org/10.1136/jmedgenet-2017-104752
- O’Brien, K. M., Orlow, I., Antonescu, C. R., Ballman, K., McCall, L., Dematteo, R., & Engel, L. S. (2013). Gastrointestinal stromal tumors: A case-only analysis of single nucleotide polymorphisms and somatic mutations. Clinical Sarcoma Research, 3(1), 12. https://doi.org/10.1186/2045-3329-3-12
- Olteanu, H., Munson, T., & Banerjee, R. (2002). Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry, 41(45), 13378–13385. https://doi.org/10.1021/bi020536s
- Päkkilä, F., Männistö, T., Pouta, A., Hartikainen, A. L., Ruokonen, A., Surcel, H. M., Bloigu, A., Vääräsmäki, M., Järvelin, M. R., Moilanen, I., & Suvanto, E. (2014). The impact of gestational thyroid hormone concentrations on ADHD symptoms of the child. The Journal of clinical endocrinology and metabolism, 99 (1), E1–E8. https://doi.org/10.1210/jc.2013-2943
- Ratti, A., Corrado, L., Castellotti, B., Del Bo, R., Fogh, I., Cereda, C., & Consortium, S. L. A. G. E. N. (2012). C9ORF72 repeat expansion in a large Italian ALS cohort: Evidence of a founder effect. Neurobiology of Aging, 33(10), 2528.e7-2528.14. https://doi.org/10.1016/j.neurobiolaging.2012.06.008
- Renton, A. E., Majounie, E., Waite, A., SimÃn-Sánchez, J., Rollinson, S., Gibbs, J. R., & Consortium, I. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72(2), 257–268. https://doi.org/10.1016/j.neuron.2011.09.010
- Saha, T., Chatterjee, M., Verma, D., Ray, A., Sinha, S., Rajamma, U., & Mukhopadhyay, K. (2018). Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 84(Pt A), 1–10. [pii]. https://doi.org/10.1016/j.pnpbp.2018.01.016
- Sahin, N., Altun, H., Kurutas, E. B., & Balkan, D. (2018). Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder. Neuropsychiatric disease and treatment, 14: 581–585. https://doi.org/10.2147/NDT.S158228
- Scassellati, C., Zanardini, R., Tiberti, A., Pezzani, M., Valenti, V., Effedri, P., & Bocchio-Chiavetto, L. (2014). Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). European Child & Adolescent Psychiatry, 23(3), 173–177. https://doi.org/10.1007/s00787-013-0447-1
- Silverman, H. E., Goldman, J. S., & Huey, E. D. (2019). Links between the C9orf72 repeat expansion and psychiatric symptoms. Current Neurology and Neuroscience Reports, 19(12), 93-019-1017-9. https://doi.org/10.1007/s11910-019-1017-9
- Solje, E., Miettunen, J., Marttila, R., Helisalmi, S., Laitinen, M., Koivumaa-Honkanen, H., & Remes, A. M. (2016). The C9ORF72 expansion sizes in patients with psychosis: A population-based study on the Northern Finland Birth Cohort 1966. Psychiatric Genetics, 26(2), 92–94. https://doi.org/10.1097/YPG.0000000000000118
- Souza, P. V., Pinto, W. B., & Oliveira, A. S. (2015). C9orf72-related disorders: Expanding the clinical and genetic spectrum of neurodegenerative diseases. Arquivos De Neuro-Psiquiatria, 73(3), 246–256. https://doi.org/10.1590/0004-282X20140229
- Tsetsos, F., Padmanabhuni, S. S., Alexander, J., Karagiannidis, I., Tsifintaris, M., Topaloudi, A., & Paschou, P. (2016). Meta-analysis of tourette syndrome and attention deficit hyperactivity disorder provides support for a shared genetic basis. Frontiers in Neuroscience, 10, 340. https://doi.org/10.3389/fnins.2016.00340
- Valbonesi, S., Magri, C., Traversa, M., Faraone, S. V., Cattaneo, A., Milanesi, E., & Scassellati, C. (2015). Copy number variants in attention-deficit hyperactive disorder: Identification of the 15q13 deletion and its functional role. Psychiatric Genetics, 25(2), 59–70. https://doi.org/10.1097/YPG.0000000000000056
- van der Meer, D., Hoekstra, P. J., van Donkelaar, M., Bralten, J., Oosterlaan, J., Heslenfeld, D., Faraone, S. V., Franke, B., Buitelaar, J. K., & Hartman, C. A. (2017). Predicting attention-deficit/hyperactivity disorder severity from psychosocial stress and stress-response genes: a random forest regression approach. Translational psychiatry, 7(6), e1145. https://doi.org/10.1038/tp.2017.114
- Van Mossevelde, S., van der Zee, J., Cruts, M., & Van Broeckhoven, C. (2017). Relationship between C9orf72 repeat size and clinical phenotype. Current Opinion in Genetics & Development, 44, 117–124. [pii]. https://doi.org/10.1016/j.gde.2017.02.008
- Watson, A., Pribadi, M., Chowdari, K., Clifton, S., Joel, W., Miller, B. L., & Nimgaonkar, V. (2016). C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis. Psychiatry Research, 235, 200–202. https://doi.org/10.1016/j.psychres.2015.12.007
- Xi, Z., Zinman, L., Grinberg, Y., Moreno, D., Sato, C., Bilbao, J. M., & Rogaeva, E. (2012). Investigation of c9orf72 in 4 neurodegenerative disorders. Archives of Neurology, 69(12), 1583–1590. https://doi.org/10.1001/archneurol.2012.2016
- Zettergren, A., Karlsson, S., Hovey, D., Jonsson, L., Melke, J., Anckarsäter, H., Lichtenstein, P., Lundström, S., & Westberg, L. (2016). Further investigations of the relation between polymorphisms in sex steroid related genes and autistic-like traits. Psychoneuroendocrinology, 68, 1–5. https://doi.org/10.1016/j.psyneuen.2016.02.020
- Zucchi, E., Ticozzi, N., & Mandrioli, J. (2019). Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Frontiers in Neuroscience, 13, 175. https://doi.org/10.3389/fnins.2019.00175